TM
Tessier-Lavigne Marc Director
Board M
US US · SEC (Form 4)
Browse the detailed record of transactions filed by Tessier-Lavigne Marc, Director. Director active across 2 companies, notably Denali Therapeutics Inc.. In total, 20 disclosures have been published. Total volume traded: €4.3m. The latest transaction was filed on 2 June 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations 20 total
05,986 shares 0
Common Stock
SEC:0001714899-22-000096:0 · 2 Jun 2022
€254,427 8,402 shares @ €30.2818 0.0099% mcap 4.7% of flow
Common Stock
SEC:0001714899-22-000061:0 · 23 Mar 2022
€3m 7,439 shares @ €344.9654 0.0035% mcap 30.2% of flow
Common Stock
SEC:0001708138-22-000027:0 · 21 Mar 2022
€1m 4,361 shares @ €341.059 0.0020% mcap 17.5% of flow
Common Stock
SEC:0001708138-22-000020:0 · 16 Mar 2022
0191 shares 0
Common Stock
SEC:0001883850-22-000008 · 3 Jan 2022
0191 shares 0
Common Stock
SEC:0001883850-22-000008:0 · 3 Jan 2022
0300,000 shares 0
Common Stock
SEC:0001714899-21-000117 · 4 Oct 2021
0300,000 shares 0
Common Stock
SEC:0001714899-21-000117:0 · 4 Oct 2021
€1m 3,784 shares @ €327.352 0.0017% mcap 55.7% of flow
Common Stock
SEC:0001237899-21-000027 · 9 Dec 2021
€1m 3,784 shares @ €327.352 0.0017% mcap 14.6% of flow
Common Stock
SEC:0001237899-21-000027:0 · 9 Dec 2021
€984,678 4,250 shares @ €231.689 0.0013% mcap 44.3% of flow
Common Stock
SEC:0001708138-21-000080 · 13 Sept 2021
€984,678 4,250 shares @ €231.689 0.0013% mcap 11.6% of flow
Common Stock
SEC:0001708138-21-000080:0 · 13 Sept 2021
€580,183 39,303 shares @ €14.7618 0.023% mcap 22.3% of flow
Common Stock
SEC:0001209191-21-038978 · 7 Jun 2021
€580,183 39,303 shares @ €14.7618 0.023% mcap 10.6% of flow
Common Stock
SEC:0001209191-21-038978:0 · 7 Jun 2021
02,074 shares 0
Common Stock
SEC:0001209191-21-038393 · 2 Jun 2021
02,074 shares 0
Common Stock
SEC:0001209191-21-038393:0 · 2 Jun 2021
€2m 37,957 shares @ €49.187 0.072% mcap 71.7% of flow
Common Stock
SEC:0001209191-21-035548 · 21 May 2021
€2m 37,957 shares @ €49.187 0.072% mcap 34.2% of flow
Common Stock
SEC:0001209191-21-035548:0 · 21 May 2021
€156,361 3,139 shares @ €49.8123 0.0061% mcap 6.0% of flow
Common Stock
SEC:0001209191-21-030304 · 3 May 2021
€156,361 3,139 shares @ €49.8123 0.0061% mcap 2.9% of flow
Common Stock
SEC:0001209191-21-030304:0 · 3 May 2021
About Tessier-Lavigne Marc Marc Tessier-Lavigne is an executive at Denali Therapeutics Inc.